Related Experiment Video
Updated: Aug 8, 2026
09:42
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
Aberrant methylation: common in thymic carcinomas, rare in thymomas
Makoto Suzuki1, Hong Chen, Hisayuki Shigematsu
1Department of Thoracic Surgery, Graduate School of Medicine, 1-8-1 Inohana, Chuoh-ku, Chiba 260-8677, Japan. smakoto@faculty.chiba-u.jp
Oncology Reports
|November 8, 2005
Summary
Thymic carcinoma exhibits distinct clinicopathological features and higher aberrant methylation patterns in tumor suppressor genes compared to thymoma. These molecular differences highlight thymic carcinoma's unique biological behavior.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Thymic carcinoma is a rare thymic epithelial neoplasm with aggressive behavior distinct from thymoma.
- Understanding the molecular mechanisms driving thymic carcinoma is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the clinicopathological features, tumor suppressor gene methylation patterns, and EGFR family mutations in thymic carcinoma versus thymoma.
- To elucidate the molecular basis for the aggressive nature of thymic carcinoma.
Main Methods:
- Clinicopathological data review of 11 thymic cancers and 13 thymomas.
- Methylation and mutation analysis of tumor suppressor genes and EGFR family genes (EGFR, KRAS, HER2) in resected samples.
- Comparison of methylation index and tumor marker positivity between thymic carcinoma and thymoma.
Main Results:
- Thymic carcinoma showed significantly higher positivity for tumor markers (p=0.0233) and a higher methylation index (p=0.0053) compared to thymoma.
- No mutations were detected in EGFR, KRAS, or HER2 in either group.
- Aberrant methylation patterns of tumor suppressor genes were significantly more prevalent in thymic carcinoma.
Conclusions:
- Thymic carcinoma is molecularly distinct from thymoma, characterized by aberrant methylation patterns of tumor suppressor genes.
- These distinct molecular features contribute to the different clinicopathological characteristics and aggressive behavior of thymic carcinoma.
Related Concept Videos
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...